Join our growing community to challenge mainstream media bias and fix the news
Blue Cross Blue Shield pledges $55 million to make generics cheaper

Blue Cross Blue Shield pledges $55 million to make generics cheaper

Blue Cross Blue Shield health insurers are working with Civica Rx, a non-profit formed two years ago, to try to increase competition for generic drugs. The insurers have committed $55 million to a new subsidiary that will focus on selling the drugs to members via mail order or in retail pharmacies starting in 2022. The pharmaceutical industry is under pressure to lower generic drug prices.

Skeptic
Skeptic
Fin
Fin 7 months

Smart n bold.. For bcbs is in trouble... Aetna n uhc and humana are buying up the markets... Slowly squeezing out bcbs

Top in Business